Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1995 1
1999 1
2006 4
2007 1
2008 1
2009 3
2010 5
2011 3
2012 5
2013 1
2014 5
2015 4
2016 2
2017 2
2018 4
2019 5
2020 7
2021 6
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management.
Huang TD, Behary J, Zekry A. Huang TD, et al. Intern Med J. 2020 Sep;50(9):1038-1047. doi: 10.1111/imj.14709. Intern Med J. 2020. PMID: 31760676 Review.
In some patients, simple steatosis can result in non-alcoholic steatohepatitis which over time can lead to liver cirrhosis and its associated sequelae, including hepatocellular carcinoma. Early identification and management of patients at risk with intensive …
In some patients, simple steatosis can result in non-alcoholic steatohepatitis which over time can lead to liver cirrhosis and its associate …
Liquid biopsy in the clinical management of hepatocellular carcinoma.
von Felden J, Garcia-Lezana T, Schulze K, Losic B, Villanueva A. von Felden J, et al. Gut. 2020 Nov;69(11):2025-2034. doi: 10.1136/gutjnl-2019-320282. Epub 2020 Sep 3. Gut. 2020. PMID: 32883873 Review.
A variety of translational liquid biopsy studies have been carried out to address clinical needs, such as early hepatocellular carcinoma detection and prediction of treatment response. To this regard, methylation profiling of circulating tumour DNA has evolve …
A variety of translational liquid biopsy studies have been carried out to address clinical needs, such as early hepatocellular …
Liver Ablation: Best Practice.
Wells SA, Hinshaw JL, Lubner MG, Ziemlewicz TJ, Brace CL, Lee FT Jr. Wells SA, et al. Radiol Clin North Am. 2015 Sep;53(5):933-71. doi: 10.1016/j.rcl.2015.05.012. Radiol Clin North Am. 2015. PMID: 26321447 Free PMC article. Review.
Tumor ablation in the liver has evolved to become a well-accepted tool in the management of increasing complex oncologic patients. At present, percutaneous ablation is considered first-line therapy for very early and early hepatocellular carcinoma …
Tumor ablation in the liver has evolved to become a well-accepted tool in the management of increasing complex oncologic patients. At presen …
Personalized treatment of patients with very early hepatocellular carcinoma.
Vitale A, Peck-Radosavljevic M, Giannini EG, Vibert E, Sieghart W, Van Poucke S, Pawlik TM. Vitale A, et al. J Hepatol. 2017 Feb;66(2):412-423. doi: 10.1016/j.jhep.2016.09.012. Epub 2016 Sep 24. J Hepatol. 2017. PMID: 27677712 Review.
Hepatocellular carcinoma (HCC), in its very early stage, is heterogeneous both in terms of liver function (i.e., presence or absence of portal hypertension, model for end-stage liver disease score, Child-Pugh score 5 or 6, bilirubin level) and tumor character …
Hepatocellular carcinoma (HCC), in its very early stage, is heterogeneous both in terms of liver function (i.e., presen …
Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management.
Rizvi S, Gawrieh S. Rizvi S, et al. Drugs Aging. 2018 Jul;35(7):589-602. doi: 10.1007/s40266-018-0556-0. Drugs Aging. 2018. PMID: 29971609 Free article. Review.
The goal of maintenance therapy should be to achieve full biochemical and histologic remission. ...Liver transplantation should be considered in the elderly patient with liver failure or early hepatocellular carcinoma if there are no significant comorb …
The goal of maintenance therapy should be to achieve full biochemical and histologic remission. ...Liver transplantation should be co …
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A, Roccarina D, Thorburn D, Davidson BR, Tsochatzis E, Gurusamy KS. Majumdar A, et al. Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2. Cochrane Database Syst Rev. 2017. PMID: 28351116 Free PMC article. Review.
BACKGROUND: Hepatocellular carcinoma (primary liver cancer) is classified in many ways. ...Management of hepatocellular carcinoma is uncertain. OBJECTIVES: To assess the comparative benefits and harms of different interventions used in the treatment of …
BACKGROUND: Hepatocellular carcinoma (primary liver cancer) is classified in many ways. ...Management of hepatocellular …
Current approaches to the treatment of early hepatocellular carcinoma.
Ye SL, Takayama T, Geschwind J, Marrero JA, Bronowicki JP. Ye SL, et al. Oncologist. 2010;15 Suppl 4:34-41. doi: 10.1634/theoncologist.2010-S4-34. Oncologist. 2010. PMID: 21115579 Free article. Review.
For patients with early-stage hepatocellular carcinoma (HCC), potentially curative treatment options exist, including liver transplantation, surgical resection, and ablation therapy. ...Differences in the applicability of transplantation are also evide …
For patients with early-stage hepatocellular carcinoma (HCC), potentially curative treatment options exist, including l …
Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.
Jarnagin WR. Jarnagin WR. Ann Surg Oncol. 2010 May;17(5):1226-33. doi: 10.1245/s10434-010-0978-3. Epub 2010 Apr 20. Ann Surg Oncol. 2010. PMID: 20405327 Free PMC article. Review.
PURPOSE AND DESIGN: The management of patients with early hepatocellular carcinoma has become increasingly complex. The most appropriate therapy largely depends on the functional status of the underlying liver. ...Ablative therapies, particularl …
PURPOSE AND DESIGN: The management of patients with early hepatocellular carcinoma has become increasingly complex. The …
The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma.
Ma S, Yang J, Li J, Song J. Ma S, et al. Tumour Biol. 2016 Jun;37(6):7405-12. doi: 10.1007/s13277-015-4582-9. Epub 2015 Dec 17. Tumour Biol. 2016. PMID: 26676639 Review.
Proliferating cell nuclear antigen (PCNA) has been suggested as a potential diagnostic biomarker for early hepatocellular carcinoma (HCC). However, its prognostic significance in HCC remains unclear. ...
Proliferating cell nuclear antigen (PCNA) has been suggested as a potential diagnostic biomarker for early hepatocellular c …
Survival and recurrence rates of hepatocellular carcinoma after treatment of chronic hepatitis C using direct acting antivirals.
Lithy RM, Elbaz T, H Abdelmaksoud A, M Nabil M, Rashed N, Omran D, Kaseb AO, O Abdelaziz A, I Shousha H. Lithy RM, et al. Eur J Gastroenterol Hepatol. 2022 Feb 1;34(2):227-234. doi: 10.1097/MEG.0000000000001972. Eur J Gastroenterol Hepatol. 2022. PMID: 33208688
BACKGROUND: Conflicting studies were proposed either suggested or denied the relationship between early hepatocellular carcinoma (HCC) recurrence and the use of direct-acting antivirals (DAAs) for chronic hepatitis C management. ...CONCLUSION: Our study repor …
BACKGROUND: Conflicting studies were proposed either suggested or denied the relationship between early hepatocellular carc …
57 results